Re:: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer

被引：8
|
作者：
Ménard, S [1 ]
Camerini, T [1 ]
Mariani, L [1 ]
Tomasic, G [1 ]
Pilotti, S [1 ]
Costa, A [1 ]
De Palo, G [1 ]
Veronesi, U [1 ]
机构：
[1] Natl Canc Inst, European Inst Oncol, I-20133 Milan, Italy
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 03期
关键词：
D O I：
10.1093/jnci/93.3.240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：240 / 241
页数：2
相关论文
共 50 条
  • [1] Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
    Veronesi, U
    De Palo, G
    Marubini, E
    Costa, A
    Formelli, F
    Mariani, L
    Decensi, A
    Camerini, T
    Del Turco, MR
    Di Mauro, MG
    Muraca, MG
    Del Vecchio, M
    Pinto, C
    D'Aiuto, G
    Boni, C
    Campa, T
    Magni, A
    Miceli, R
    Perloff, M
    Malone, WF
    Sporn, MB
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) : 1847 - 1856
  • [2] 15-year results of a randomized trial of fenretinide to prevent second breast cancer
    Decensi, A
    De Palo, G
    Mariani, L
    Camerini, T
    Miceli, R
    Di Mauro, MG
    Formelli, F
    Costa, A
    Marubini, E
    Sporn, MB
    Veronesi, U
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2695S - 2695S
  • [3] Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer
    Veronesi, U.
    Mariani, L.
    Decensi, A.
    Formelli, F.
    Camerini, T.
    Miceli, R.
    Di Mauro, M. G.
    Costa, A.
    Marubini, E.
    Sporn, M. B.
    De Palo, G.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (07) : 1065 - 1071
  • [4] Fenretinide can halve the risk of second breast cancer in premenopausal women
    [J]. Nature Clinical Practice Oncology, 2006, 3 (8): : 408 - 408
  • [5] Fenretinide and risk reduction of second breast cancer
    Andrea Decensi
    Silvia Zanardi
    Alessandra Argusti
    Bernardo Bonanni
    Alberto Costa
    Umberto Veronesi
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 64 - 65
  • [6] Fenretinide and risk reduction of second breast cancer
    Decensi, Andrea
    Zanardi, Silvia
    Argusti, Alessandra
    Bonanni, Bernardo
    Costa, Alberto
    Veronesi, Umberto
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (02): : 64 - 65
  • [7] Re: Polychemotherapy for early breast cancer: Results from the International Adjuvant Breast Cancer Chemotherapy Randomized Trial
    Ferretti, Gianluigi
    Felici, Alessandra
    Carlini, Paolo
    Cognetti, Francesco
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18) : 1416 - 1416
  • [8] Tamoxifen and fenretinide in women with metastatic breast cancer
    J. Zujewski
    L. Pai
    L. Wakefield
    R. Giusti
    F.A. Dorr
    C. Flanders
    R. Caruso
    M. Kaiser
    L. Goodman
    M. Merino
    M. Gossard
    M.A. Noone
    A. Denicoff
    D. Venzon
    K.H. Cowan
    J.A. O'Shaughnessy
    [J]. Breast Cancer Research and Treatment, 1999, 57 : 277 - 283
  • [9] Tamoxifen and fenretinide in women with metastatic breast cancer
    Zujewski, J
    Pai, L
    Wakefield, L
    Giusti, R
    Dorr, FA
    Flanders, C
    Caruso, R
    Kaiser, M
    Goodman, L
    Merino, M
    Gossard, M
    Noone, MA
    Denicoff, A
    Venzon, D
    Cowan, KH
    O'Shaughnessy, JA
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1999, 57 (03) : 277 - 283
  • [10] A Randomized Controlled Trial of Exercise to Prevent Bone Loss in Premenopausal Women with Breast Cancer
    Tabatabai, Laila S.
    Bloom, Joan
    Stewart, Susan
    Sellmeyer, Deborah E.
    [J]. JOURNAL OF WOMENS HEALTH, 2019, 28 (01) : 87 - 92
12345